Skip to main content

Advertisement

SpringerLink
Log in

Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study was to determine the association of anti-Sm antibodies with clinical manifestations, comorbidities, and disease damage in a large multi-ethnic SLE cohort. SLE patients (per American College of Rheumatology criteria), age ≥16 years, disease duration ≤10 years at enrollment, and defined ethnicity (African American, Hispanic or Caucasian), from a longitudinal US cohort were studied. Socioeconomic-demographic features, cumulative clinical manifestations, comorbidities, and disease damage (as per the Systemic Lupus International Collaborating Clinics Damage Index [SDI]) were determined. The association of anti-Sm antibodies with clinical features was examined using multivariable logistic regression analyses adjusting for age, gender, ethnicity, disease duration, level of education, health insurance, and smoking. A total of 2322 SLE patients were studied. The mean (standard deviation, SD) age at diagnosis was 34.4 (12.8) years and the mean (SD) disease duration was 9.0 (7.9) years; 2127 (91.6 %) were women. Anti-Sm antibodies were present in 579 (24.9 %) patients. In the multivariable analysis, anti-Sm antibodies were significantly associated with serositis, renal involvement, psychosis, vasculitis, Raynaud’s phenomenon, hemolytic anemia, leukopenia, lymphopenia, and arterial hypertension. No significant association was found for damage accrual. In this cohort of SLE patients, anti-Sm antibodies were associated with several clinical features including serious manifestations such as renal, neurologic, and hematologic disorders as well as vasculitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pisetsky DS (2012) Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification. Scand J Immunol 76:223–228

    Article  CAS  PubMed  Google Scholar 

  2. Reveille JD (2004) Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 13:290–297

    Article  CAS  PubMed  Google Scholar 

  3. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686

    Article  PubMed Central  PubMed  Google Scholar 

  4. Vilá LM, Molina MJ, Mayor AM, Peredo RA, Santaella ML, Vilá S (2006) Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus. Lupus 15:892–898

    Article  PubMed  Google Scholar 

  5. Barada FA Jr, Andrews BS, Davis JS 4th, Taylor RP (1981) Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum 24:1236–1244

    Article  PubMed  Google Scholar 

  6. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72:113–124

    Article  CAS  Google Scholar 

  7. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcón GS (1994) Survival impact of autoantibodies in systemic lupus erythematosus. J Rheumatol 21:224–228

    CAS  PubMed  Google Scholar 

  8. Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 42:276–279

    Article  CAS  Google Scholar 

  9. Font J, Cervera R, Ramos-Casals M, García-Carrasco M, Sents J, Herrero C et al (2004) Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum 33:217–230

    Article  PubMed  Google Scholar 

  10. Li J, Leng X, Li Z, Ye Z, Li C, Li X et al (2014) Chinese SLE treatment and research group registry: III. Association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus. J Immunol Res 2014:809389. doi:10.1155/2014/809389

    PubMed Central  PubMed  Google Scholar 

  11. Artim-Esen B, Çene E, Şahinkaya Y, Ertan S, Pehlivan Ö, Kamali S et al (2014) Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center. J Rheumatol 41:1304–1310

    Article  PubMed  Google Scholar 

  12. To CH, Petri M (2005) Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 52:4003–4010

    Article  CAS  PubMed  Google Scholar 

  13. Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, Abbs I et al (2003) Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 62:556–560

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Winn DM, Wolfe JF, Lindberg DA, Fristoe FH, Kingsland L, Sharp GC (1979) Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen. Arthritis Rheum 22:1334–1337

    Article  CAS  PubMed  Google Scholar 

  15. Janwityanuchit S, Verasertniyom O, Vanichapuntu M, Vatanasuk M (1993) Anti-Sm: its predictive value in systemic lupus erythematosus. Clin Rheumatol 12:350–353

    Article  CAS  PubMed  Google Scholar 

  16. Munves EF, Schur PH (1983) Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum 26:848–853

    Article  CAS  PubMed  Google Scholar 

  17. Tikly M, Burgin S, Mohanlal P, Bellingan A, George J (1996) Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol 15:261–265

    Article  CAS  PubMed  Google Scholar 

  18. Hoffman IE, Peene I, Meheus L, Huizinga TW, Cebecauer L, Isenberg D et al (2004) Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 63:1155–1158

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Prasad R, Ibañez D, Gladman D, Urowitz M (2006) Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus. Lupus 15:285–291

    Article  CAS  PubMed  Google Scholar 

  20. Alarcón GS, McGwin G Jr, Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11:95–101

    Article  PubMed  Google Scholar 

  21. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  CAS  PubMed  Google Scholar 

  22. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E et al (2000) The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 27:373–376

    CAS  PubMed  Google Scholar 

  23. Homma M, Mimori T, Takeda Y, Akama H, Yoshida T, Ogasawara T et al (1987) Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus. J Rheumatol Suppl 14(Suppl 13):188–193

    PubMed  Google Scholar 

  24. Ni JD, Yao X, Pan HF, Li XP, Xu JH, Ye DQ (2009) Clinical and serological correlates of anti-Sm autoantibodies in Chinese patients with systemic lupus erythematosus: 1,584 cases. Rheumatol Int 29:1323–1326

    Article  PubMed  Google Scholar 

  25. Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR (2004) et al; Grupo Latinoamericano de Estudio del Lupus. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”. Medicine (Baltimore) 83:1–17

    Article  Google Scholar 

  26. Arnett FC, Hamilton RG, Roebber MG, Harley JB, Reichlin M (1988) Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 15:1773–1776

    CAS  PubMed  Google Scholar 

  27. Sharp GC (1982) Anti-nRNP and anti-Sm antibodies. Arthritis Rheum 25:757–760

    Article  CAS  PubMed  Google Scholar 

  28. López-Longo FJ, López-Gómez JM, Jofre Ibáñez R, Escalona M, Rodríguez-Mahou M (1992) Prognostic value of anti-RNP/Sm and anti-Ro/La antibodies in lupus nephropathy. Rev Clin Esp 191:354–359

    PubMed  Google Scholar 

  29. Tápanes FJ, Vásquez M, Ramírez R, Matheus C, Rodríguez MA, Bianco N (2000) Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable nuclear antibodies protective? Lupus 9:437–444

    Article  PubMed  Google Scholar 

  30. López-Longo FJ, González Fernández CM, Rodríguez Mahou M, Grau Simó R, Monteagudo Sáez I, Meno García AC et al (1997) [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies]. Rev Clin Esp 197:329–335

    PubMed  Google Scholar 

  31. Beaufils M, Kouki F, Mignon F, Camus JP, Morel-Maroger L, Richet G (1983) Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Am J Med 74:201–205

    Article  CAS  PubMed  Google Scholar 

  32. Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM (1988) Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 47:918–923

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Martínez-Cordero E, Martínez-Miranda E, Negrete-García MC, Padilla A, Aguilar León DE (1992) Anti-dsDNA and Sm autoantibodies in systemic lupus erythematosus. Clin Rheumatol 11:341–345

    Article  PubMed  Google Scholar 

  34. Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, Drosos AA, Moutsopoulos HM (1993) Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus 2:303–312

    Article  CAS  PubMed  Google Scholar 

  35. Ishizaki J, Saito K, Nawata M, Mizuno Y, Tokunaga M, Sawamukai N, et al (2014) Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. Rheumatology (Oxford) Sep 2. pii: keu343

  36. Yasuma M, Takasaki Y, Matsumoto K, Kodama A, Hashimoto H, Hirose S (1990) Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. J Rheumatol 17:469–475

    CAS  PubMed  Google Scholar 

  37. Winfield JB, Brunner CM, Koffler D (1978) Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum 21:289–294

    Article  CAS  PubMed  Google Scholar 

  38. Hirohata S, Kosaka M (1994) Association of anti-Sm antibodies with organic brain syndrome secondary to systemic lupus erythematosus. Lancet 343:796

    Article  CAS  PubMed  Google Scholar 

  39. Hirohata S, Sakuma Y, Yanagida T, Yoshio T (2014) Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus. Arthritis Res Ther 16:450

    Article  PubMed Central  PubMed  Google Scholar 

  40. Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD et al (2012) Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum 42:179–185

    Article  PubMed  Google Scholar 

  41. Tang X, Huang Y, Deng W, Tang L, Weng W, Zhang X (2010) Clinical and serologic correlations and autoantibody clusters in systemic lupus erythematosus: a retrospective review of 917 patients in South China. Medicine (Baltimore) 89:62–67

    Article  Google Scholar 

  42. Gripenberg M, Teppo AM, Friman C (1991) Antibodies to Sm and SS-A demonstrated by enzyme immunoassay. Correlation to clinical manifestations and disease activity in patients with systemic lupus erythematosus. Rheumatol Int 11:209–213

    Article  CAS  PubMed  Google Scholar 

  43. Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón G, et al (2014) Anti-C1q antibodies in systemic lupus erythematosus. Lupus; 14

  44. Alarcón GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, LUMINA Study Group et al (2001) Lupus in minority populations, nature versus nurture. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 44:2797–2806

    Article  PubMed  Google Scholar 

  45. Mannik M, Merrill CE, Stamps LD, Wener MH (2003) Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 30:1495–1504

    PubMed  Google Scholar 

  46. Van Duijnhoven HL, Van De Warenburg FJ, Willems RJ, Ermens AM (1999) A comparison of ELISA assays as routine diagnostic test for detection of autoantibodies against extractable nuclear antigens. Clin Biochem 32:179–183

    Article  PubMed  Google Scholar 

  47. Fisher DE, Reeves WH, Wisniewolski R, Lahita RG, Chiorazzi N (1985) Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum 28:1348–1355

    Article  CAS  PubMed  Google Scholar 

  48. Meyer O, Aeschlimann A, Bourgeois P, Kahn MF (1990) Longitudinal immunoblotting variations of auto-antibody reactivity of patients with systemic lupus erythematosus. Autoimmunity 7:23–31

    Article  CAS  PubMed  Google Scholar 

  49. Ippolito A, Wallace DJ, Gladman D, Fortin PR, Urowitz M, Werth V et al (2011) Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus 20:250–255

    Article  CAS  PubMed  Google Scholar 

  50. McCarty GA, Harley JB, Reichlin M (1993) A distinctive autoantibody profile in black female patients with lupus nephritis. Arthritis Rheum 36:1560–1565

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases: R01 AR064820 (University of Alabama Birmingham [UAB]—Coordinating Site, Johns Hopkins University [JHU], Northwestern University [NU], University of Puerto Rico [UPR], and University of Texas Health Science Center at Houston [UTH]), P01 AR49084 (UAB) AR43727 (JHU), R01 AR42503 (UAB), K24-AR002138 (NU), P60AR048098 (NU), P60AR064464 (NU), and R01-AR42503 (UTH); grants from the Center of Clinical & Translational Science: UL1 TR000165 (UAB) and 8UL1TR000150 (NU), and General Clinical Research Centers: M01-RR00052 (JHU), M01-RR00048 (NU), and M01-RR02558 (UTH); and the National Institute of Health and Health Disparities grant number 8U54MD007587 (UPR), and by an unrestricted educational grant from Abbvie (UPR).

Disclosure

None.

Ethical standards

The Institutional Review Board of each institution approved this study, and written informed consent was obtained from all participating subjects according to the Declaration of Helsinki.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, University of Puerto Rico Medical Sciences Campus, PO Box 365067, San Juan, PR, 00936-5067, USA

    Mariangelí Arroyo-Ávila, Yesenia Santiago-Casas & Luis M. Vilá

  2. Department of Epidemiology, School of Public Health University of Alabama at Birmingham, Birmingham, AL, USA

    Gerald McGwin Jr & Ryan S. Cantor

  3. Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Michelle Petri

  4. Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Rosalind Ramsey-Goldman

  5. Division of Rheumatology, Department of Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA

    John D. Reveille

  6. Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

    Robert P. Kimberly, Graciela S. Alarcón & Elizabeth E. Brown

  7. Department of Pathology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA

    Elizabeth E. Brown

Authors
  1. Mariangelí Arroyo-Ávila
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yesenia Santiago-Casas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerald McGwin Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryan S. Cantor
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michelle Petri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rosalind Ramsey-Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. John D. Reveille
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Robert P. Kimberly
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Graciela S. Alarcón
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Luis M. Vilá
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Elizabeth E. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luis M. Vilá.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arroyo-Ávila, M., Santiago-Casas, Y., McGwin, G. et al. Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort. Clin Rheumatol 34, 1217–1223 (2015). https://doi.org/10.1007/s10067-015-2941-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-2941-y

Keywords

Search

Navigation